| |
Supplementary data - overview
| Aaboe M, Birkenkamp-Demtroder K, Wiuf C, Sørensen
FB, Thykjaer T, Sauter G, Møller-Ernst Jensen K, Dyrskjøt
L, Ørntoft TF. SOX4 expression in bladder carcinoma:
clinical aspects and in vitro functional characterization. Cancer
Research. 2006. Apr 1;66(7):3434-42. PubMed |
data |
| Colombo M, Kruhoeffer M, Gregersen S, Agger
A, Jeppesen P, Orntoft T, Hermansen K. Energy restriction
prevents the development of type 2 diabetes in Zucker diabetic fatty
rats: coordinated patterns of gene expression for energy metabolism
in insulin-sensitive tissues and pancreatic islets determined by
oligonucleotide microarray analysis. Metabolism. 2006 Jan;55(1):43-52.
PubMed
|
data |
| Colombo M, Gregersen S, Kruhoeffer M, Agger
A, Xiao J, Jeppesen PB, Orntoft T, Ploug T, Galbo H, Hermansen K.
Prevention of hyperglycemia in Zucker diabetic fatty rats
by exercise training: effects on gene expression in insulin-sensitive
tissues determined by high-density oligonucleotide microarray analysis,
Metabolism, 54: 1571-1581, 2005. PubMed |
data |
| Aaboe M, Marcussen N, Jensen KM, Thykjaer T,
Dyrskjot L, Orntoft TF. Gene expression profiling of noninvasive
primary urothelial tumours using microarrays. Br J Cancer. 2005
Nov 1; [Epub ahead of print] PubMed
|
data |
| Dyrskjøt L, Zieger K, Kruhøffer
M, Thykjaer T, Jensen JL, Primdahl H, Aziz N, Marcussen N, Møller
K and Ørntoft TF. A molecular signature in superficial
bladder carcinoma predicts clinical outcome. Clinical Cancer Research.
2005. June 1, 11 (11): PubMed
|
data |
| Koed, K., Wiuf,C., Christensen, L.L., Wikman,
F., Zieger, K., Møller, K., von der Maase, H., Ørntoft, T.F. High-density single nucleotide polymorphism array
defines novel stage and location-dependent allelic imbalances in
human bladder tumors. Cancer Research. 2005. 65 (1):34-45. PubMed |
data |
| Andersen C.L., Ledet-Jensen
J., Ørntoft T.: Normalization of real-time
quantitative RT-PCR data: a model based variance estimation approach
to identify genes suited for normalization - applied to bladder-
and colon-cancer data-sets. Cancer Research.
2004 (64):
5245-5250. PubMed |
data |
| Dyrskjot,L., Kruhoffer,M., Thykjaer,T., Marcussen,N.,
Jensen,J.L., Moller,K., Orntoft,T.F. Gene expression in the urinary
bladder: a common carcinoma in situ gene expression signature
exists disregarding histopathological classification. Cancer Res..
64(11): 4040-4048. 2004. PubMed |
supplementary
information
GEO
data |
| Dyrskjot,L.,
Thykjaer,T., Kruhoffer,M., Jensen,J.L., Marcussen,N., Hamilton-Dutoit,S.,
Wolf,H., Orntoft,T.F. Identifying distinct classes of bladder
carcinoma using microarrays. Nat.Genet..
33(1): 90-96. 2003. PubMed |
GEO data:
GSE88
GSE89
|
| Primdahl,H., Wikman,F.P., von
der,Maase H., Zhou,X.G., Wolf,H., Orntoft,T.F. Allelic imbalances in human
bladder cancer: genome-wide detection with high-density single-nucleotide
polymorphism arrays. J.Natl.Cancer Inst.. 94(3): 216-223. 2002. PubMed |
data |
| Thykjaer,T., Workman,C., Kruhoffer,M., Demtroder,K.,
Wolf,H., Andersen,L.D., Frederiksen,C.M., Knudsen,S., Orntoft,T.F.
Identification of gene expression
patterns in superficial and invasive human bladder cancer. Cancer
Res.. 61(6): 2492-2499. 2001. PubMed |
data |
| Olesen,S.H., Thykjaer,T., Orntoft,T.F. Mitotic checkpoint genes hBUB1,
hBUB1B, hBUB3 and TTK in human bladder cancer, screening for mutations
and loss of heterozygosity. Carcinogenesis. 22(5): 813-815. 2001.
PubMed |
data |
| Wikman,F.P., Lu,M.L., Thykjaer,T.,
Olesen,S.H., Andersen,L.D., Cordon-Cardo,C., Orntoft,T.F. Evaluation of the performance
of a p53 sequencing microarray chip using 140 previously sequenced
bladder tumor samples. Clin.Chem.. 46(10): 1555-1561. 2000. PubMed |
data |
| Celis,J.E., Kruhoffer,M., Gromova,I.,
Frederiksen,C., Ostergaard,M., Thykjaer,T., Gromov,P., Yu,J.,
Palsdottir,H., Magnusson,N., Orntoft,T.F. Gene expression profiling:
monitoring transcription and translation products using DNA microarrays
and proteomics. FEBS Lett.. 480(1): 2-16. 2000. PubMed
|
FEBS Letter |
|